Genus PLC (GNS.L) stock: key figures, P/E, revenue and dividend

Health Care · United Kingdom · ISIN GB0002074580

Price
23.10 GBP
Market cap
1.55 bn GBP
P/E (2026)
5.43
P/S (2026)
2.36
Dividend yield
1.42 %
Net margin
43.35 %
Return on equity (ROE)
37.21 %
Return on assets (ROA)
28.02 %

Genus PLC financials

Fiscal year20252026
Revenue672.00 m GBP658.10 m GBP
Gross profit217.00 m GBP658.10 m GBP
Operating income–87.30 m GBP
EBIT68.00 m GBP–
Net income19.00 m GBP285.30 m GBP
Diluted EPS – continuing operations0.29 GBP4.25 GBP

Full history since 1996, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Genus PLC

Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It offers dairy and beef bull semen and embryos under the Genus and Bovec brands; breeding pork and semen, as well as technical services and advice under the PIC brand. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 28.10.2026. Details in the risk notice.